triumph 1 trial retatrutide TRIUMPH-1 Results: 28% Weight Loss — Is This the End of Obesity? TRIUMPH-1 Trial Results Show Promising
Description
GLP-1 signaling has been shown to inhibit activation of the NLRP3 inflammasome, a key driver of innate immune-mediated inflammation, and to enhance Treg activity, suggesting a broader role in restoring immune tolerance [26,27]
Conclusion The intersection of GLP-1 weight loss medications and life insurance underwriting is creating new challenges for agents and clients alike
Available online: [DOI] [PMC free article] [PubMed] 62.Douton J.E., Horvath N., Mills-Huffnagle S., Nyland J.E., Hajnal A., Grigson P.S
Frequently asked questions How long does it take to reach maximum tirzepatide dose
Some patients obtain prescriptions through telehealth services with minimal evaluation, raising safety concerns
& Lipscombe, L
